Abstract

Nicotine replacement therapies (NRT), in the form of nicotine patch, gum, lozenge, nasal spray and inhaler, are primarily licensed as aids to long-term smoking cessation. The evidence that they are safe and effective at increasing smokers' chances of long-term quitting is very solid (1,2). It is also clear that one important mechanism of action of NRTs is that they reduce the severity of nicotine withdrawal symptoms and cravings to smoke (3,4).

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.